Vitamin D Deficiency and Body Composition in the Patients With Hemophilia
Association of Vitamin D Deficiency, Sarcopenia, Body Composition, Osteoporosis and Hemophilic Arthropathy in the Patients With Hemophilia
1 other identifier
observational
80
1 country
1
Brief Summary
Hemophilia is associated with osteoporosis and increased prevalence of low bone mineral density (BMD). Many clinical risk factors have been reported, such as hemophilic arthropathy, reduced physical activity, decreased sun exposure, hepatitis C virus infections, vitamin D deficiency, and low body mass index (BMI). There is no data on the prevalence of vitamin D deficiency and low BMD in hemophilia patients in Taiwan or Asia. To the best of our knowledge, no previous studies have reported the prevalence of sarcopenia and correlation with osteoporosis in hemophilia adult patients. The purpose of this study will evaluate the prevalence of vitamin D deficiency, low BMD, sarcopenia and body composition in a cohort of patients with hemophilia in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedAugust 13, 2024
August 1, 2024
3 years
August 24, 2022
August 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Vitamin D
serum vitamin D
one day
Secondary Outcomes (5)
Bone marrow density
one day
Body composition
one day
Pettersson score
one day
Hemophilia Joint Health Score
one day
Handgrip strength
one day
Study Arms (2)
Hemophilia Group
Hemophilia adult patients
Control Group
Healthy adult subjects
Eligibility Criteria
60 hemophilia patients and 20 healthy subjects
You may qualify if:
- Hemophilia patients
You may not qualify if:
- Severe diseases affecting bone metabolism (such as primary hyperparathyroidism, hypogonadism),
- History of total hip arthroplasty
- History of instrumentation in lumbar spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tsung-Ying Lilead
Study Sites (1)
Hemophilia care and research center
Taipei, 114, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tsung Ying Li, Dr
No.325,Sec.2, Cheng-Kung Rd. Neihu 11490, Taipei, Taiwan, R.O.C
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
August 24, 2022
First Posted
August 26, 2022
Study Start
January 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
August 13, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share